Table 2.
Clinical Significance of SNHG16 in Diverse Cancers
Cancer Type | Overexpression of SNHG16 and Clinical Features | References |
---|---|---|
Non-small cell cancer | Tumor size, TNM stage, lymph node metastasis, shorter DFS and OS | [32] |
Hepatocellular carcinoma | TNM stage, metastasis | [29] |
Tumor size, TNM stage, ALT (U/L) | [14] | |
Shorter DFS and OS, multiple tumors, macro vascular invasion | [26] | |
Shorter DFS and OS | [28] | |
Lymph node involvement, TNM stage | [27] | |
Tumor size, TNM stage, vascular invasion | [25] | |
Tumor size, TNM stage, metastasis, portal vein tumor thrombus (PVTT) | [30] | |
Cervical cancer | Tumor size, FIGO stage, lymph node metastasis, poor differentiation | [34,35] |
Osteosarcoma | Tumor size, TNM stage, metastasis, shorter OS | [39] |
Tumor size, TNM stage, distance, metastasis, shorter OS | [41] | |
Papillary thyroid cancer | TNM stage, lymph nodes, | [42] |
Glioma | Tumor size, WHO stage, shorter OS and PFS, | [51] |
Colorectal cancer | Metastasis, lymph node metastasis | [13] |
Ovarian cancer | Clinical stage, distance metastasis, shorter OS | [53] |
Bladder cancer | Historical grade, tumor stage, lymph node metastasis | [35] |
Metastasis, lymph nodes, pathological stage | [34] | |
Gastric cancer | Lymph node metastasis, invasive depth, TNM stage | [67] |
Pancreatic cancer | Tumor size, TNM stage, lymph node metastasis, differentiation | [41] |